TY - DATA
T1 - Data underlying the PhD thesis: Computational approaches to dissect immunotherapy response in breast cancer
PY - 2025/02/17
AU - Olga Isaeva
UR - 
DO - 10.4121/1881e4a5-55ff-4b51-984b-3d9a2dda1821.v1
KW - breast cancer
KW - covid-19
KW - immunotherapy
KW - lobular breast cancer
KW - checkpoint inhibitors
KW - bioinformatics
KW - RNA-Seq
KW - WES
KW - TNBC
KW - tumor immunology
N2 - <p>Code underlying the publications described in the thesis. The dataset includes the Python 3, R and bash scripts for bioinformatic analyses included in the following research papers:</p><p><br></p><p>1) <span style="color: rgb(34, 34, 34);">Nederlof, I., Isaeva, O.I., de Graaf, M.&nbsp;</span><em style="color: rgb(34, 34, 34);">et al.</em><span style="color: rgb(34, 34, 34);">&nbsp;Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial.&nbsp;</span><em style="color: rgb(34, 34, 34);">Nat Med</em><span style="color: rgb(34, 34, 34);">&nbsp;</span><strong style="color: rgb(34, 34, 34);">30</strong><span style="color: rgb(34, 34, 34);">, 3223–3235 (2024). https://doi.org/10.1038/s41591-024-03249-3</span></p><p><span style="color: rgb(34, 34, 34);">2) Voorwerk, L., Isaeva, O.I., Horlings, H.M.&nbsp;</span><em style="color: rgb(34, 34, 34);">et al.</em><span style="color: rgb(34, 34, 34);">&nbsp;PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial.&nbsp;</span><em style="color: rgb(34, 34, 34);">Nat Cancer</em><span style="color: rgb(34, 34, 34);">&nbsp;</span><strong style="color: rgb(34, 34, 34);">4</strong><span style="color: rgb(34, 34, 34);">, 535–549 (2023). https://doi.org/10.1038/s43018-023-00542-x</span></p><p><span style="color: rgb(34, 34, 34);">3) Gangaev, A., Ketelaars, S.L.C., Isaeva, O.I.&nbsp;</span><em style="color: rgb(34, 34, 34);">et al.</em><span style="color: rgb(34, 34, 34);">&nbsp;Identification and characterization of a SARS-CoV-2 specific CD8+&nbsp;T cell response with immunodominant features.&nbsp;</span><em style="color: rgb(34, 34, 34);">Nat Commun</em><span style="color: rgb(34, 34, 34);">&nbsp;</span><strong style="color: rgb(34, 34, 34);">12</strong><span style="color: rgb(34, 34, 34);">, 2593 (2021). https://doi.org/10.1038/s41467-021-22811-y</span></p>
ER -